Editas Medicine Announces Fourth Quarter and Full Year 2022 Results and Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. BE

Go back to Editas Medicine Announces Fourth Quarter and Full Year 2022 Results and Business Updates

Editas Medicine (EDIT) Misses Q4 EPS by 9c

February 22, 2023 6:16 AM EST

Editas Medicine (NASDAQ: EDIT) reported Q4 EPS of ($0.88), $0.09 worse than the analyst estimate of ($0.79). Revenue for the quarter came in at $6.5 million versus the consensus estimate of $3.66 million.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

... More